Effectiveness of therapeutic and pharmacological interventions in the treatment of cannabis dependence: a narrative review
DOI:
https://doi.org/10.25118/2763-9037.2024.v14.1301Keywords:
cannabis use disorder, therapeutic approaches, pharmacotherapy, narrative review, marihuanaAbstract
This study reviewed therapeutic and pharmacological interventions for the treatment of Cannabis use disorder. Review studies that directly addressed therapeutic, pharmacological, or psychosocial interventions for cannabis dependence were included. The search identified 430 articles, of which 11 were included in the review. The results highlighted findings on pharmacotherapy, mixed interventions, psychotherapies, and digital treatments. We conclude that while there are promising interventions, such as behavioral therapies and digital programs, more rigorous research is needed to effectively address problematic cannabis use.
Downloads
Metrics
References
Clarke R, Merlin M. Cannabis: evolution and ethnobotany. Oakland: University of California Press; 2016. http://www.jstor.org/stable/10.1525/j.ctt3fh2f8
Braithwaite I, Newton-Howes G, Oldfield K, Semprini A. Cannabis-based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic? N Z Med J. 2019;132(1500):82–8.
Lima MCM, Valença MM, Machado CE, Melo Pereira ME, Brant PK. Uso da Cannabis medicinal e autismo. J Meml Med. 2020;2(1):5-14. https://doi.org/10.37085/jmmv2.n1.2020.pp.5-14 DOI: https://doi.org/10.37085/jmmv2.n1.2020.pp.5-14
Medeiros FC, Soares PB, Jesus RA, Teixeira DG, Alexandre MM, Sabec GZ. Uso medicinal da Cannabis sativa (Cannabaceae) como alternativa no tratamento da epilepsia. Braz J Dev. 2020;6(6):41510-23. https://doi.org/10.34117/bjdv6n6-623 DOI: https://doi.org/10.34117/bjdv6n6-623
Murnion B. Medicinal Cannabis. Aust Prescr. 2015;38(6).
https://doi.org/10.18773/austprescr.2015.072 - PMid:26843715 PMCid:PMC4674028 DOI: https://doi.org/10.18773/austprescr.2015.072
Britto LR, Araújo AN, Araújo RPC. Associações entre o uso de Cannabis e esquizofrenia: uma revisão da literatura. Rev. Ciênc. Med. Biol. 2016;15(1):95–102. https://doi.org/10.9771/cmbio.v15i1.16156 DOI: https://doi.org/10.9771/cmbio.v15i1.16156
Nascimento IC, Zocante A, Braide SM, Chaves FF, Oliveira Ferreira GL, Rezende LF. Relação entre Cannabis e psicose. Rev Universidade Vale Rio Verde. 2015;13(1):186-9.
https://doi.org/10.5892/ruvrd.v13i1.1946 DOI: https://doi.org/10.5892/ruvrd.v13i1.1946
Hall W. Getting to grips with the Cannabis problem: the evolving contributions and impact of Griffith Edwards. Addict Abingdon Engl. 2015; 110:36-9. https://doi.org/10.1111/add.12907 PMid:26042566 DOI: https://doi.org/10.1111/add.12907
Di Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, Bianconi F, Gardner-Sood P, O'Connor J, Russo M, Stilo SA, Marques TR, Mondelli V, Dazzan P, Pariante C, David AS, Gaughran F, Atakan Z, Iyegbe C, Powell J, Morgan C, Lynskey M. Proportion of patients in south London with first-episode psychosis attributable to use of high potency Cannabis: a case-control study. Lancet Psychiatry. 2015;2(3):233-8. https://doi.org/10.1016/S2215-0366(14)00117-5 - PMid:26359901 DOI: https://doi.org/10.1016/S2215-0366(14)00117-5
Hasin DS, Sarvet AL, Cerdá M, Keyes KM, Stohl M, Galea S, Wall MM. US adult illicit Cannabis use, Cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017;74(6):579-88. https://doi.org/10.1001/jamapsychiatry.2017.0724 DOI: https://doi.org/10.1001/jamapsychiatry.2017.0724
PMid:28445557 - PMCid:PMC5539836
Ribeiro GCA, Vieira W de A, Herval ÁM, Rodrigues RPCB, Agostini BA, Flores-Mir C, Repeke CEP, Paranhos LR. Prevalence of mental disorders among elderly men: a systematic review and meta-analysis. Sao Paulo Med J. 2020;138(3):190–200. https://doi.org/10.1590/1516-3180.2019.0454.R1.16012020 DOI: https://doi.org/10.1590/1516-3180.2019.0454.r1.16012020
Myers B, Petersen-Williams P, van der Westhuizen C, Lund C, Lombard C, Joska JA, Levitt NS, Butler C, Naledi T, Milligan P, Stein DJ, Sorsdah K. Community health worker-delivered counselling for common mental disorders among chronic disease patients in South Africa: a feasibility study. BMJ Open. 2019;9(1): e024277. https://doi.org/10.1136/bmjopen-2018-024277 PMid:30647043 PMCid:PMC6340481 DOI: https://doi.org/10.1136/bmjopen-2018-024277
Kondo K, Morasco BJ, Nugent S, Ayers C, O'Neil ME, Freeman M, Kansagara D. Pharmacotherapy for the treatment of Cannabis use disorder: a systematic review. Washington (DC): Department of Veterans Affairs (US); 2019. https://doi.org/10.7326/M19-1105 PMid:32120384 DOI: https://doi.org/10.7326/M19-1105
Sharma R, Tikka SK, Bhute AR, Bastia BK . N-acetyl cysteine in the treatment of Cannabis use disorder: a systematic review of clinical trials. Addict Behav. 2022;129:107283. DOI: https://doi.org/10.1016/j.addbeh.2022.107283
https://doi.org/ 10.1016/j.addbeh.2022.107283
Marshall K. Pharmacotherapies for Cannabis dependence. 2014 | Cochrane Library. Disponível em: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858 DOI: https://doi.org/10.1002/14651858.CD008940.pub2
Bahji A, Meyyappan AC, Hawken ER, Tibbo PG. Pharmacotherapies for Cannabis use disorder: a systematic review and network meta-analysis. Int J Drug Policy. 2021; 97:103295.
https://doi.org/10.1016/j.drugpo.2021.103295 - PMid:34062288 PMCid:PMC8881089 DOI: https://doi.org/10.1016/j.drugpo.2021.103295
Senderovich H, Patel P, Jimenez Lopez B, Waicus S. A systematic review on Cannabis hyperemesis syndrome and its management options. Med Princ Pract. 2022;31(1):29-38.
https://doi.org/10.1159/000520417 - PMid:34724666 PMCid:PMC8995641 DOI: https://doi.org/10.1159/000520417
Sabioni P, Le Foll B. Psychosocial and pharmacological interventions for the treatment of Cannabis use disorder. FOCUS. 2019;17(2):163-8.
https://doi.org/10.1176/appi.focus.17202 - PMid:32021586 PMCid:PMC6527000 DOI: https://doi.org/10.1176/appi.focus.17202
Olmos A, Tirado-Muñoz J, Farré M, Torrens M. The efficacy of computerized interventions to reduce Cannabis use: systematic review and meta-analysis. Addict Behav. 2018;79:52-60. https://doi.org/10.1016/j.addbeh.2017.11.045 - PMID:29248863 DOI: https://doi.org/10.1016/j.addbeh.2017.11.045
Nassif YB, Rahioui H, Varescon I. Psychological interventions for Cannabis use among adolescents and young adults: a systematic review. Int J Environ Res Public Health. 2023;20(14):6346. https://doi.org/10.3390/ijerph20146346 - PMID:37510578 PMCID:PMC:10380066 DOI: https://doi.org/10.3390/ijerph20146346
Walsh H, McNeill A, Purssell E, Duaso M. A systematic review and Bayesian meta-analysis of interventions which target or assess co-use of tobacco and Cannabis in single- or multi-substance interventions. Addiction. 2020;115(10):1800-14.
https://doi.org/10.1111/add.14993 - PMid:32003088 DOI: https://doi.org/10.1111/add.14993
Bonfiglio NS, Mascia ML, Cataudella S, Penna MP. Digital help for substance users (SU): a systematic review. Int J Environ Res Public Health. 2022;19(18):11309. https://doi.org/10.3390/ijerph19181130 DOI: https://doi.org/10.3390/ijerph191811309
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Marcia Andrea da Silva Carvalho Sombra, Milton Armando Teresa Malai Moçambique, Lucas Cavalcante Sombra, Gabriel Antonio Roberto, Renata Reis Frizon, Aristone José Pacheco Marinho, Isabella Scalabrini Ferrari, Pedro Eugênio Mazzucchi Santana Ferreira
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
